Press releases

April 01, 2009- Siemens reinforces portfolio with process industry software

With a workforce of 60, Elan Software Systems is a software and solutions supplier specializing in Manufacturing Execution Systems in the pharmaceutical and biotech industries. This global player with its focus in France will be assigned to the Industrial Automation Systems Business Unit. "Particularly for the pharmaceutical and biotech industries, the Elan product range ideally supplements our Simatic IT MES portfolio, which is itself already a leader in its field. Elan has excellent manufacturing process know-how in these industries, where it has been a recognized partner and preferred software supplier to many well-known companies for twenty years. On this foundation we intend to build our worldwide MES software business in these industries", said Ralf-Michael Franke, Business Unit CEO. According to Franke, Elan's business activities ideally complement the Siemens process industry portfolio, such as the Simatic IT MES portfolio, the process control system PCS 7 and the Comos lifecycle management systems added in 2008 by the acquisition of Innotec." We will be continuing our successful strategy. Our customers can go on counting on our outstanding range of products and services and also rely on a strong partner under the Siemens roof who can offer them security of investment ", commented Jean-Pierre Amadio, Managing Director of Elan Software Systems SA.

For further information on the Internet, go to: www.siemens.com/automation

This press release is published without a photo.

You can also find the text on the Internet at: www.siemens.com/automation/press

Elan Software Systems SA (Toulouse, France) is a leading supplier of Manufacturing Execution Systems (MES) products and solutions for the pharmaceutical and biotech industries. The modern XFP MES Suite software gives Elan's international customers in these industries a global competitive edge. Elan's portfolio of products and services is developed in close partnership with leading companies in the pharmaceutical and biotech industries.

The Siemens Industry Sector (Erlangen, Germany) is the worldwide leading supplier of production, transportation, building and lighting technologies. With integrated automation technologies as well as comprehensive industry-specific solutions, Siemens increases the productivity, efficiency and flexibility of its customers in the fields of industry and infrastructure. The Sector consists of six Divisions: Building Technologies, Drive Technologies, Industry Automation, Industry Solutions, Mobility and Osram. With around 222,000 employees worldwide Siemens Industry posted in fiscal year 2008 a profit of EUR3.86 billion with revenues totalling EUR38 billion. www.siemens.com/industry

The Siemens Industry Automation Division (Nuremberg, Germany) is a worldwide leader in the fields of automation systems, low-voltage switchgear and industrial software. Its portfolio ranges from standard products for the manufacturing and process industries to solutions for whole industrial sectors that encompass the automation of entire automobile production facilities and chemical plants. As a leading software supplier, Industry Automation optimizes the entire value added chain of manufacturers – from product design and development to production, sales and a wide range of maintenance services. With around 42,900 employees worldwide Siemens Industry Automation achieved in fiscal year 2008 total sales of EUR8.7 billion.

This document contains forward-looking statements and information – that is, statements related to future, not past, events. These statements may be identified by words such as “expects,” “looks forward to,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “will,” “project” or words of similar meaning. Such statements are based on our current expectations and certain assumptions, and are, therefore, subject to certain risks and uncertainties. A variety of factors, many of which are beyond Siemens’ control, affect our operations, performance, business strategy and results and could cause the actual results, performance or achievements of Siemens to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements. For us, particular uncertainties arise, among others, from changes in general economic and business conditions (including margin developments in major business areas); the challenges of integrating major acquisitions and implementing joint ventures and other significant portfolio measures; changes in currency exchange rates and interest rates; introduction of competing products or technologies by other companies; lack of acceptance of new products or services by customers targeted by Siemens; changes in business strategy; the outcome of pending investigations and legal proceedings, especially the corruption investigation we are currently subject to in Germany, the United States and elsewhere; the potential impact of such investigations and proceedings on our ongoing business including our relationships with governments and other customers; the potential impact of such matters on our financial statements; as well as various other factors. More detailed information about certain of these factors is contained throughout this report and in our other filings with the SEC, which are available on the Siemens website, www.siemens.com, and on the SEC's website, www.sec.gov. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the relevant forward-looking statement as expected, anticipated, intended, planned, believed, sought, estimated or projected. Siemens does not intend or assume any obligation to update or revise these forward-looking statements in light of developments which differ from those anticipated.

For more informations : https://mes-simaticit.siemens.com/html/